Study Group: Affymetrix and Illumina SNP Chips Users (US)
Council Members in this Study Group: 31
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
B. Michael SilberChief of Drug Discovery R&D and Professor
University of California, San Francisco - CC
Michael Silber, PhD, is Professor of Neurology, Bioengineering and Therapeutic Sciences, and Chief of Drug Discovery R & D, at the Institute for Neurodegenerative Diseases, UCSF School of Medicine. He has 25 years of experience as a senior leader in Pharma...
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Academic Institution*
- Office Based Private Practice or Clinic
- Research Foundation
- Pharmaceuticals Manufacturer
- Medical Equipment & Supplies Manufacturer
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Director
- Physician - Director
- Professor
- Research Scientist
- Researcher
- Owner
- National Marketing Director
- President
Related Study Groups
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.